SynthesisScientific reports2022

Surrogacy analysis of intermediate end-points for overall survival in randomized controlled trials of rhabdomyosarcoma.

Yuta Kubota et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.